---
figid: PMC7854724__41467_2020_20290_Fig6_HTML
figlink: pmc/articles/PMC7854724/figure/Fig6/
number: Fig. 6
caption: Prior to fusion, myocytes originating from the DML (in orange) express the
  ligand TGFB3, the effectors SMAD 3, & 4 and the receptor TGFBR1. They are competent
  to fuse. Myoblasts originating from the posterior or anterior borders of the somite
  (in blue) express TGFBR2. Upon fusion of myoblasts to DML-derived myocytes, membrane
  merging of the fusion partners allow the activation of the TGFβ pathway by a receptor
  heterodimer complementation mechanism (in purple), ultimately leading to a temporary
  inhibition of fusion of another myoblast. The process of fusion is likely reinitiated
  after RAB-mediated receptor degradation.
pmcid: PMC7854724
papertitle: TGFβ signalling acts as a molecular brake of myoblast fusion.
reftext: Julie Melendez, et al. Nat Commun. 2021;12:749.
pmc_ranked_result_index: '65318'
pathway_score: 0.9682681
filename: 41467_2020_20290_Fig6_HTML.jpg
figtitle: TGFB signalling acts as a molecular brake of myoblast fusion
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7854724__41467_2020_20290_Fig6_HTML.html
  '@type': Dataset
  description: Prior to fusion, myocytes originating from the DML (in orange) express
    the ligand TGFB3, the effectors SMAD 3, & 4 and the receptor TGFBR1. They are
    competent to fuse. Myoblasts originating from the posterior or anterior borders
    of the somite (in blue) express TGFBR2. Upon fusion of myoblasts to DML-derived
    myocytes, membrane merging of the fusion partners allow the activation of the
    TGFβ pathway by a receptor heterodimer complementation mechanism (in purple),
    ultimately leading to a temporary inhibition of fusion of another myoblast. The
    process of fusion is likely reinitiated after RAB-mediated receptor degradation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - ALPL
  - TGFBR2
  - TGFBR1
  - SMAD4
  - SMAD3
  - SMAD2
genes:
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: AL/PL
  symbol: ALPL
  source: hgnc_symbol
  hgnc_symbol: ALPL
  entrez: '249'
- word: TGFB3
  symbol: TGFB3
  source: hgnc_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGFBR2
  symbol: TGFBR2
  source: hgnc_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: TGFBR1
  symbol: TGFBR1
  source: hgnc_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: AL/PL
  symbol: ALPL
  source: hgnc_symbol
  hgnc_symbol: ALPL
  entrez: '249'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SMAD2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
chemicals: []
diseases: []
---
